1300亿，黑石、TPG扫货

Core Viewpoint - The acquisition of Hologic by Blackstone and TPG marks a significant event in the medical technology sector, with a transaction value of up to $18.3 billion, making it one of the largest medical device deals in nearly two decades [6][13][17]. Company Overview - Hologic, founded in 1985, focuses on women's health and has developed a range of products that benefit over 100 million patients globally each year [7][9]. - The company has established itself in various areas including breast health, molecular diagnostics, pathology, gynecological surgery, ultrasound imaging, and skeletal health [12]. Acquisition Details - The acquisition agreement stipulates a maximum price of $79 per share, with the total deal amount reaching $18.3 billion (approximately 130.4 billion yuan) [6][17]. - Blackstone and TPG will acquire all outstanding shares of Hologic at $76 in cash, along with an additional contingent value right that could yield up to $3 per share based on future performance [17][18]. Financial Performance - Hologic's financial struggles included a downward revision of revenue expectations and a significant drop in stock price, with a decline of over 25% within five months [15][16]. - For the first three quarters of fiscal 2025, Hologic reported total revenue of $3.051 billion, a year-on-year increase of 0.28%, while net profit decreased by 38.04% to $379 million [16]. Strategic Implications - The involvement of Abu Dhabi Investment Authority (ADIA) and Singapore's GIC as minority shareholders highlights the strategic interest in Hologic's potential for growth in women's health [6][17]. - Hologic's CEO expressed confidence that the resources and expertise of Blackstone and TPG will enhance the company's ability to provide critical medical technologies to global customers [17][18].